UK Body Urges Action On Licensing Delays As MHRA Unveils Guidance For Established Products
Regulator Aims To Shorten Timeframes For Assessment Of Established Medicines
UK MHRA guidance outlining process changes aimed at shortening timeframes for assessing established medicines has been welcomed by the BGMA, which has emphasized the need to clear the regulator’s current approvals backlog that the association says is exacerbating shortages.
